Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
50 participants
OBSERVATIONAL
2016-11-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Extended Spectrum Betalactamase Producing Bacteria; Epidemiology and Treatment in Non-hospitalized Patients
NCT01838213
Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities
NCT03477084
Treatment of Extended Spectrum Betalactamase Producing Bacteria Causing Urinary Tract Infections in General Practice
NCT01531023
Infections Caused by ESbL-Producing Enterobacteriaceae in Italy
NCT00404625
ESBL in Patients Returning to Sweden With Traveller's Diarrhoea
NCT03866291
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
120 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sorlandet Hospital HF
OTHER_GOV
Helse Stavanger HF
OTHER_GOV
Sykehuset Telemark
OTHER_GOV
Oslo University Hospital
OTHER
Sykehuset Ostfold
OTHER
University Hospital, Akershus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Silje Bakken Jørgensen
Head of section, infection control officer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Silje B Jørgensen, MD
Role: PRINCIPAL_INVESTIGATOR
Akershus univversitetssykehus HF
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-086
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.